“Bicycle Therapeutics Ltd, a new biotechnology company developing a novel technology platform for the identification and optimisation of chemically constrained cyclic peptides with high target specificity and binding affinity, has signed a License agreement with the Ecole Polytechnique Federale de Lausanne (EPFL) in Lausanne, Switzerland and has secured additional seed funding from SR One, the […]
Bicycle Therapeutics signs license agreement with EPFL and adds SR One and SVLS to Seed Syndicate
Cancer-causing viruses exploit genetic achilles heel, finds study
“Scientists say some viruses can turn cells into ‘viral hotels’ by exploiting tiny molecules derived from human DNA. The UK study [directed by Cancer Research UK and in collaboration with LMB] found that some viruses can boost microRNA activity to suppress the immune system’s reaction to them.” More…
Potential new target for Asthma treatment discovered
Researchers at LMB, lead by Dr Andrew McKenzie, have discovered a novel cell type that could lead to the development of new treatments for asthma, a disease that affects the lives of 5.4 million people in the UK. The new cells, named nuocytes, are a key early source of Interleukin 13 (IL-13), a crucial immune […]
Studying the Individual Cell
“Researchers are taking advantage of new tools and techniques in imaging, sequencing, and proteomics to zoom in on what single cells are doing … Paul Dear at the MRC Laboratory of Molecular Biology says that single-cell analysis is going to explode — and test the paradigm that all cells in a body have identical genomes. […]
Clocking off: the new science of sleep
“Does your body run like clockwork? As Week 7 fatigue sets in, Michael Hastings writes on what recent discoveries in genetics mean for our sleeping patterns … Dr Michael Hastings is a Cambridge neuroscientist, based at the MRC Laboratory of Molecular Biology, specialising in the molecular neurobiology of circadian body clocks.” More…
Newly elected Fellows
“Seventy-eight microbiologists have been elected to Fellowship in the American Academy of Microbiology. Fellows of the Academy are elected annually through a highly selective, peer-review process, based on their records of scientific achievement and original contributions that have advanced microbiology… including Andrew A. Travers”. This article is no longer available from the source website: American […]